Shantell Laketa Heiber

Array ( [id] => 3825211 [patent_doc_number] => 05759825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Method for synthesizing 2-ketoaldonic acids' [patent_app_type] => 1 [patent_app_number] => 8/475777 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17306 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759825.pdf [firstpage_image] =>[orig_patent_app_number] => 475777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240686 [patent_doc_number] => 06136318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Recombinant fowlpox viruses and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/486414 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33350 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136318.pdf [firstpage_image] =>[orig_patent_app_number] => 486414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985873 [patent_doc_number] => 05891442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Infectious bursal disease virus recombination poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/480697 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10259 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891442.pdf [firstpage_image] =>[orig_patent_app_number] => 480697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109527 [patent_doc_number] => 06045802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule' [patent_app_type] => 1 [patent_app_number] => 8/483316 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 17233 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045802.pdf [firstpage_image] =>[orig_patent_app_number] => 483316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835116 [patent_doc_number] => 05744141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Flavivirus recombinant poxvirus immunological composition' [patent_app_type] => 1 [patent_app_number] => 8/484304 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 28232 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744141.pdf [firstpage_image] =>[orig_patent_app_number] => 484304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825459 [patent_doc_number] => 05759841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Immunological composition of measles virus utilizing recombinant poxvirus' [patent_app_type] => 1 [patent_app_number] => 8/487412 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18538 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759841.pdf [firstpage_image] =>[orig_patent_app_number] => 487412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218494 [patent_doc_number] => 06010704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them' [patent_app_type] => 1 [patent_app_number] => 8/467281 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13927 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010704.pdf [firstpage_image] =>[orig_patent_app_number] => 467281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935440 [patent_doc_number] => 05989561 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses' [patent_app_type] => 1 [patent_app_number] => 8/471025 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 34217 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989561.pdf [firstpage_image] =>[orig_patent_app_number] => 471025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244633 [patent_doc_number] => 06221577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Seroreactive regions on HPV 16-proteins E1 and E2' [patent_app_type] => 1 [patent_app_number] => 8/468337 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5224 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221577.pdf [firstpage_image] =>[orig_patent_app_number] => 468337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006172 [patent_doc_number] => 05962217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof' [patent_app_type] => 1 [patent_app_number] => 8/470006 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 18276 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962217.pdf [firstpage_image] =>[orig_patent_app_number] => 470006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933690 [patent_doc_number] => 05871745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Multiple sclerosis related virus' [patent_app_type] => 1 [patent_app_number] => 8/471969 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 17733 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871745.pdf [firstpage_image] =>[orig_patent_app_number] => 471969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730430 [patent_doc_number] => 05698202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier' [patent_app_type] => 1 [patent_app_number] => 8/461837 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 31 [patent_no_of_words] => 8885 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698202.pdf [firstpage_image] =>[orig_patent_app_number] => 461837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842974 [patent_doc_number] => 05766599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Trova fowl pox virus recombinants comprising heterologous inserts' [patent_app_type] => 1 [patent_app_number] => 8/458101 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 55 [patent_no_of_words] => 138495 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766599.pdf [firstpage_image] =>[orig_patent_app_number] => 458101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881653 [patent_doc_number] => 05723122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases' [patent_app_type] => 1 [patent_app_number] => 8/456566 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6224 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723122.pdf [firstpage_image] =>[orig_patent_app_number] => 456566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3765476 [patent_doc_number] => 05756103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Alvac canarypox virus recombinants comprising heterlogous inserts' [patent_app_type] => 1 [patent_app_number] => 8/457007 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 55 [patent_no_of_words] => 122223 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756103.pdf [firstpage_image] =>[orig_patent_app_number] => 457007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811704 [patent_doc_number] => 05789177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1' [patent_app_type] => 1 [patent_app_number] => 8/454730 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 15200 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789177.pdf [firstpage_image] =>[orig_patent_app_number] => 454730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888492 [patent_doc_number] => 05834307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Polynucleotides encoding CMV neutralizing proteins' [patent_app_type] => 1 [patent_app_number] => 8/449671 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12343 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834307.pdf [firstpage_image] =>[orig_patent_app_number] => 449671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809295 [patent_doc_number] => 05709865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)' [patent_app_type] => 1 [patent_app_number] => 8/445746 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 16680 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/709/05709865.pdf [firstpage_image] =>[orig_patent_app_number] => 445746 [rel_patent_id] =>[rel_patent_doc_number] =>)